The number of CD8+CD3+ T-granzyme B [apoptotic effector secreted by cytotoxic T lymphocytes (ctl)] positive cells also increased, attributed to the enhanced immune response elicited by the efficient delivery and release of anti-PD-L1 to gliomas. The gene discussed is CD8A; the disease is glioma.